Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04938232 |
|---|---|
| Brief Title: | Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL |
| First Submitted : | June 8, 2021 |
| First Submitted that Met QC Criteria : | June 22, 2021 |
| First Posted : | June 24, 2021 |
| Last Update Submitted that Met QC Criteria : | March 18, 2024 |
| Last Update Posted : | March 20, 2024 |